SEC Filings

Filing date	Form	Description	View
09/08/14	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-14-065070.pdf 0001104659-14-065070.rtf 0001104659-14-065070.xls
09/08/14	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-14-065202.pdf 0001104659-14-065202.rtf 0001104659-14-065202.xls
08/26/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-013305.pdf 0001179110-14-013305.rtf 0001179110-14-013305.xls
08/22/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-013187.pdf 0001179110-14-013187.rtf 0001179110-14-013187.xls
08/18/14	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001104659-14-061602.pdf 0001104659-14-061602.rtf 0001104659-14-061602.xls
08/14/14	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001104659-14-060469.pdf 0001104659-14-060469.rtf 0001104659-14-060469.xls EX-101.INS - XBRL INSTANCE DOCUMENT
08/13/14	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-14-060394.pdf 0001104659-14-060394.rtf 0001104659-14-060394.xls
08/06/14	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-14-057607.pdf 0001104659-14-057607.rtf 0001104659-14-057607.xls
07/28/14	CT ORDER	CT ORDER	View HTML 9999999997-14-012376.pdf
07/23/14	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-14-011976.pdf 0001179110-14-011976.rtf 0001179110-14-011976.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.